| Targeting cell cycle regulation in cancer therapy S Diaz-Moralli, M Tarrado-Castellarnau, A Miranda, M Cascante Pharmacology & therapeutics 138 (2), 255-271, 2013 | 419 | 2013 |
| Oncogenic regulation of tumor metabolic reprogramming M Tarrado-Castellarnau, P de Atauri, M Cascante Oncotarget 7 (38), 62726, 2016 | 152 | 2016 |
| Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation S Diaz-Moralli, M Tarrado-Castellarnau, C Alenda, A Castells, ... PloS one 6 (9), e25323, 2011 | 72 | 2011 |
| De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition M Tarrado‐Castellarnau, P de Atauri, J Tarragó‐Celada, J Perarnau, ... Molecular systems biology 13 (10), 940, 2017 | 60 | 2017 |
| Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition M Tarrado-Castellarnau, R Cortes, M Zanuy, J Tarragó-Celada, IH Polat, ... Pharmacological research 102, 218-234, 2015 | 60 | 2015 |
| A novel cyclometallated Pt(ii)–ferrocene complex induces nuclear FOXO3a localization and apoptosis and synergizes with cisplatin to inhibit lung cancer cell … R Cortés, M Tarrado-Castellarnau, D Talancón, C López, W Link, D Ruiz, ... Metallomics 6 (3), 622-633, 2014 | 38 | 2014 |
| Glyceraldehyde-3-phosphate dehydrogenase is overexpressed in colorectal cancer onset M Tarrado-Castellarnau, S Diaz-Moralli, IH Polat, R Sanz-Pamplona, ... Translational Medicine Communications 2, 1-9, 2017 | 22 | 2017 |
| Oxidative pentose phosphate pathway enzyme 6-phosphogluconate dehydrogenase plays a key role in breast cancer metabolism IH Polat, M Tarrado-Castellarnau, R Bharat, J Perarnau, A Benito, ... Biology 10 (2), 85, 2021 | 19 | 2021 |
| Glutamine modulates expression and function of glucose 6-phosphate dehydrogenase via NRF2 in colon cancer cells IH Polat, M Tarrado-Castellarnau, A Benito, C Hernandez-Carro, ... Antioxidants 10 (9), 1349, 2021 | 18 | 2021 |
| Cysteine and folate metabolism are targetable vulnerabilities of metastatic colorectal cancer J Tarragó-Celada, C Foguet, M Tarrado-Castellarnau, S Marin, ... Cancers 13 (3), 425, 2021 | 16 | 2021 |
| Study of the heat transfer during the alkaline treatment in the processing of Spanish style green table olives M Tarrado-Castellarnau, JMD Ortega, A Tarrado-Castellarnau, ... Grasas y Aceites 64 (4), 415-424, 2013 | 7 | 2013 |
| Oncogenic regulation of tumor metabolic reprogramming. Oncotarget. 2016; 7: 62726–53 M Tarrado-Castellarnau, P de Atauri, M Cascante | 5 | |
| Estudio de la transferencia de calor en la etapa de cocido en la elaboración de aceitunas verdes al estilo sevillano M Tarrado-Castellarnau, JM Domínguez Ortega, A Tarrado-Castellarnau, ... Consejo Superior de Investigaciones Científicas (CSIC), 2014 | 3 | 2014 |
| Integrating systemic and molecular levels to infer key drivers sustaining metabolic adaptations P de Atauri, M Tarrado-Castellarnau, J Tarragó-Celada, C Foguet, ... PLoS Computational Biology 17 (7), e1009234, 2021 | 2 | 2021 |
| Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells M Tarrado-Castellarnau, C Foguet, J Tarragó-Celada, M Palobart, ... bioRxiv, 2024.01. 04.574237, 2024 | | 2024 |
| Retifanlimab and the arginase inhibitor CB-1158 show low activity in microsatellite-stable colorectal cancer patient-derived organoids co-cultured with tumor-infiltrating … C Bayo, S Marín, S Madurga, S Lahoz, I Archilla, R Bravo, M Cuatrecasas, ... | | 2023 |
| Glutamine modulates expression and function of glucose 6-phosphate dehydrogenase via NRF2 in colon cancer cells. I Halil Polat, MN Tarrado Castellarnau, A Benito Mauricio, ... Antioxidants, 2021, vol. 10, num. 9, p. 1-16, 2021 | | 2021 |
| Integrating systemic and molecular levels to infer key drivers sustaining metabolic adaptations R Atauri Carulla, MN Tarrado Castellarnau, J Tarragó-Celada, ... PLoS Computational Biology, 2021, vol. 17, num. 7, p. e1009234, 2021 | | 2021 |
| Supplementary dataset for journal article" De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition" M Tarrado‐Castellarnau, P Atauri, J Tarragó‐Celada, J Perarnau, ... Zenodo, 2017 | | 2017 |
| Targeting metabolic reprogramming associated to cancer cells: search of novel targets and combined therapies in cancer treatment MN Tarrado Castellarnau Universitat de Barcelona, 2015 | | 2015 |
Marta CascanteUniversitat de Barcelona在 ub.edu 的电子邮件经过验证
